Halscarb 150 Injection 15 ml

Halscarb 150 Injection 15 ml belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.

Halscarb 150 Injection 15 ml contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.

Halscarb 150 Injection 15 ml is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of Halscarb 150 Injection 15 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

To treat your condition effectually, continue taking Halscarb 150 Injection 15 ml for as long as your doctor has prescribed. Do not stop the Halscarb 150 Injection 15 ml midway. Talk to your doctor before taking Halscarb 150 Injection 15 ml if you have severe allergic reactions to Halscarb 150 Injection 15 ml or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Halscarb 150 Injection 15 ml should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Halscarb 150 Injection 15 ml if you are pregnant or breastfeeding because this Halscarb 150 Injection 15 ml can cause harmful effects on the unborn baby. Both women and men using this Halscarb 150 Injection 15 ml should use birth control to avoid pregnancy.

Halscarb 150 Injection 15 ml is used in the treatment of various types of cancer. The detailed uses of Halscarb 150 Injection 15 ml include:

• Treatment of ovarian cancer: Halscarb 150 Injection 15 ml is indicated for the initial and advanced treatment of ovarian cancer, often in combination with other anticancer medicines.
• Management of small cell lung cancer (SCLC): Halscarb 150 Injection 15 ml is used to treat small cell lung cancer, particularly in cases where the cancer has spread or is in an advanced stage.
• Chemotherapy regimen component: Halscarb 150 Injection 15 ml works by interfering with the growth of cancer cells, eventually destroying them.
• Combination therapy benefit: Halscarb 150 Injection 15 ml is often used alongside other chemotherapy drugs to improve treatment outcomes and reduce the risk of recurrence.

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Halscarb 150 Injection 15 ml will be administered by the doctor or healthcare professional.
• Do not self-administer.

Halscarb 150 Injection 15 ml contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.

Halscarb 150 Injection 15 ml should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Halscarb 150 Injection 15 ml. To treat your condition effectually, continue taking Halscarb 150 Injection 15 ml for as long as your doctor has prescribed. Do not stop the Halscarb 150 Injection 15 ml midway. Talk to your doctor before taking Halscarb 150 Injection 15 ml if you have severe allergic reactions to Halscarb 150 Injection 15 ml or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Halscarb 150 Injection 15 ml should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Halscarb 150 Injection 15 ml if you are pregnant or breastfeeding because this Halscarb 150 Injection 15 ml can cause harmful effects on the unborn baby. Both women and men using this Halscarb 150 Injection 15 ml should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during Halscarb 150 Injection 15 ml treatment and appropriate until recovery is achieved.